Patents by Inventor Patrick Halvey

Patrick Halvey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190048417
    Abstract: The present invention features methods of treating a subject having an autoimmune disease and/or inflammation including determining the genotype, and/or the glycophenotype of the subject and administering to the subject an Fc-activity modulating agent or an anti-TNF? agent based on the genotype and/or the glycophenotype of the subject. The invention also features methods of predicting the responsiveness of a patient to an anti-TNF? treatment by identifying a patient having inflammation or an autoimmune disease, determining the genotype, or glycophenotype of the subject, and selecting the patient for treatment with an Fc-activity modulating agent or an anti-TNF? agent based on the genotype and/or the glycophenotype of the subject.
    Type: Application
    Filed: September 30, 2016
    Publication date: February 14, 2019
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventors: Nathaniel Washburn, Patrick Halvey, Kevin McConnell, Victor Farutin, Ishan Capila, Leona E. Ling, Anthony Manning